Hatem Alameri1, Yusra Al-Kabab, Ahmed BaHammam. 1. Pulmonary Division and Pulmonary Physiology Laboratory, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Abstract
PURPOSE: Several studies have used the cardiopulmonary exercise test to assess patients with obstructive sleep apnea (OSA). However, no report has investigated the use of the 6-min walk test (6MWT) in this group of patients. METHODS: We studied consecutive, newly diagnosed, OSA patients (aged >18 years). The control group was composed of matched healthy subjects with no clinical history indicative of sleep breathing disorders. The study population was divided into three groups: an OSA group, a control obese group, and a control lean group. The obese controls were gender-, age- (+/-2 years), height- (+/-5 cm), and weight- (+/-2 kg) matched to the OSA patients, while the lean controls were matched in gender, age, and height, but not weight. All patients underwent sleep study at our Sleep Disorders Center. Each subject underwent a single 6MWT within 1 week of the sleep study. RESULTS: A total of 55 patients were recruited to the OSA group (age 36.7 +/- 7.9 years, body mass index 38.7 +/- 8.6 kg/m(2), and apnea hypopnea index 66.6 +/- 34.8/h), 32 subjects to the control obese group, and 30 to the control lean group. There was no difference in distance walked (6-min walk distance (6MWD)) between the OSA group (389 +/- 70 m) and the obese group (408 +/- 66 m). In the OSA group, the 6MWD results did not correlate with patient age, apnea hypopnea index, or other polysomnographic variables. At the end of the test, heart rate, systolic and diastolic blood pressure, and dyspnea perception were significantly increased in the OSA group compared with healthy subjects. CONCLUSIONS: The 6MWT is easy to perform and well tolerated by patients with OSA. There were no correlations between the 6MWD and the severity of OSA or other polysomnographic parameters. However, patients with OSA exhibited abnormal hemodynamic responses to submaximal exercise.
PURPOSE: Several studies have used the cardiopulmonary exercise test to assess patients with obstructive sleep apnea (OSA). However, no report has investigated the use of the 6-min walk test (6MWT) in this group of patients. METHODS: We studied consecutive, newly diagnosed, OSA patients (aged >18 years). The control group was composed of matched healthy subjects with no clinical history indicative of sleep breathing disorders. The study population was divided into three groups: an OSA group, a control obese group, and a control lean group. The obese controls were gender-, age- (+/-2 years), height- (+/-5 cm), and weight- (+/-2 kg) matched to the OSA patients, while the lean controls were matched in gender, age, and height, but not weight. All patients underwent sleep study at our Sleep Disorders Center. Each subject underwent a single 6MWT within 1 week of the sleep study. RESULTS: A total of 55 patients were recruited to the OSA group (age 36.7 +/- 7.9 years, body mass index 38.7 +/- 8.6 kg/m(2), and apnea hypopnea index 66.6 +/- 34.8/h), 32 subjects to the control obese group, and 30 to the control lean group. There was no difference in distance walked (6-min walk distance (6MWD)) between the OSA group (389 +/- 70 m) and the obese group (408 +/- 66 m). In the OSA group, the 6MWD results did not correlate with patient age, apnea hypopnea index, or other polysomnographic variables. At the end of the test, heart rate, systolic and diastolic blood pressure, and dyspnea perception were significantly increased in the OSA group compared with healthy subjects. CONCLUSIONS: The 6MWT is easy to perform and well tolerated by patients with OSA. There were no correlations between the 6MWD and the severity of OSA or other polysomnographic parameters. However, patients with OSA exhibited abnormal hemodynamic responses to submaximal exercise.
Authors: Kevin R Flaherty; Adin-Cristian Andrei; Susan Murray; Chris Fraley; Thomas V Colby; William D Travis; Vibha Lama; Ella A Kazerooni; Barry H Gross; Galen B Toews; Fernando J Martinez Journal: Am J Respir Crit Care Med Date: 2006-07-06 Impact factor: 21.405
Authors: Thomas E Vanhecke; Barry A Franklin; Kerstyn C Zalesin; R Bart Sangal; Adam T deJong; Varun Agrawal; Peter A McCullough Journal: Chest Date: 2008-09 Impact factor: 9.410
Authors: Hannah V Fletcher; Peter S P Cho; Stewart Lee Loong; Luis Estrada-Petrocelli; Amit S Patel; Surinder S Birring; Kai K Lee Journal: J Clin Sleep Med Date: 2020-11-15 Impact factor: 4.062
Authors: Michele Vitacca; Mara Paneroni; Alberto Braghiroli; Bruno Balbi; Maria Aliani; Patrizia Guido; Francesco Fanfulla; Mario Pertosa; Piero Ceriana; Elisabetta Zampogna; Rita Raccanelli; Nicola Sarno; Antonio Spanevello; Mauro Maniscalco; Alberto Malovini; Nicolino Ambrosino Journal: J Clin Sleep Med Date: 2020-04-15 Impact factor: 4.062
Authors: Bruno Teixeira Barbosa; Amilton da Cruz Santos; Murillo Frazão; Tulio Rocha Petrucci; Gabriel Grizzo Cucato; Adriana Oliveira Sarmento; Eduardo D S Freitas; Anna Myrna Jaguaribe de Lima; Maria do Socorro Brasileiro-Santos Journal: Sleep Breath Date: 2017-08-24 Impact factor: 2.816
Authors: Matheus Gustavo Silva Magalhães; Juliana Baptista Teixeira; Ana Maria Bezerra Santos; Danielle Cristina Silva Clímaco; Thayse Neves Santos Silva; Anna Myrna Jaguaribe de Lima Journal: J Bras Pneumol Date: 2020-04-22 Impact factor: 2.800